EPISODE · Jan 25, 2024 · 13 MIN
The Pharmaceutical Rivalry Behind the Weight-Loss Drug Boom
from Big Take · host Bloomberg and iHeartPodcasts
The multi-billion dollar weight-loss drug market has ballooned in the past few years. And the two pharmaceutical companies currently duking it out for market dominance, Novo Nordisk and Eli Lilly, have a century-long rivalry. Bloomberg News health reporter Madison Muller breaks down how Eli Lilly developed Zepbound, a new drug that can help patients cut more than 20% of their body weight — and why some investors and analysts think it will turn Eli Lilly into the first ever trillion-dollar drug company.(Corrects characterization of the current size of the weight-loss drug market)See omnystudio.com/listener for privacy information.
NOW PLAYING
The Pharmaceutical Rivalry Behind the Weight-Loss Drug Boom
No transcript for this episode yet
Similar Episodes
Feb 4, 2026 ·18m
Sep 22, 2023 ·20m
Sep 22, 2023 ·20m
Sep 22, 2023 ·27m
Sep 22, 2023 ·14m
Sep 22, 2023 ·24m